Scalper1 News
Biotech stocks have rocketed to the top of IBD’s industry group rankings thanks in part to huge moves last week by a couple of former laggards. Three weeks ago, the Medical-Biomedical/Biotech group was ranked 35th out of the 197 industries tracked by IBD. But the group jumped 17% last week after Intercept Pharmaceuticals (ICPT) rocketed more than 500% on strong results for its experimental liver-disease drug. However, the stock fell sharply Monday Scalper1 News
Scalper1 News